Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

98.73
+1.431.47%
Volume:7K
Turnover:644.33K
Market Cap:406.77M
PE:55.06
High:98.82
Open:97.68
Low:97.68
Close:97.30
52wk High:98.82
52wk Low:67.56
Shares:4.12M
Float Shares:4.12M
Volume Ratio:0.28
T/O Rate:0.16%
Dividend:1.55
Dividend Rate:1.57%
EPS(TTM):1.79
EPS(LYR):18.65
ROE:24.76%
ROA:0.08%
PB:1.64
PE(LYR):5.29

Loading ...

Sino Biopharmaceutical Stock Slips 1.2% in Hong Kong

Dow Jones
·
Aug 05

Street View: Amgen Builds Momentum with Blockbusters, Biosimilars and a Pipeline in Waiting

Reuters
·
Aug 05

Amgen Inc : Morgan Stanley Raises Target Price to $351 from $333

THOMSON REUTERS
·
Aug 05

Amgen Inc : Oppenheimer Raises Target Price to $450 from $400

THOMSON REUTERS
·
Aug 05

Dow Jones Top Company Headlines at 7 PM ET: SpaceX Revenue Could Reach $1 Trillion, Elon Musk Says | Paramount's ...

Dow Jones
·
Aug 05

Amgen Announces Availability of Q2 2026 Earnings Report Release

Reuters
·
Aug 05

Amgen's Strong Second Quarter Drug Sales Drive Upward Forecast Revision and Early-Stage Weight Loss Drug Termination

Deep News
·
Aug 05

Amgen Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 05

Amgen Exec Says Continues to Expect Capital Expenditures of About $2.6 Billion in 2026 to Scale Manufacturing Capacity, Including for Maritide's Launch

THOMSON REUTERS
·
Aug 05

Amgen Exec Says Expect a Meaningful Sequential Increase in Operating Expenses in the Third Quarter

THOMSON REUTERS
·
Aug 05

Amgen Exec Says Spent $500 Million in Q2 on Capital Expenditures, Driven by Investments Across United States Manufacturing Sites-Conf Call

THOMSON REUTERS
·
Aug 05

Amgen Q2 FY26 GAAP EPS Rises 65% to $4.37; Revenue Increases 10% to $10.1 Billion

Reuters
·
Aug 05

Amgen Inc Stock (AMGN) Closed Up by 3.03% on Aug 4: Key Drivers Unveiled

TradingKey
·
Aug 05

Amgen Second-Quarter Sales Rise 9%, Profit Tops Street View

Reuters
·
Aug 05

Amgen Outlook FY Revenue USD 38,200-39,400 Million

THOMSON REUTERS
·
Aug 05

Amgen Inc: a Phase 1 Study of Amg 513 in Adults Living with Obesity Will Remain Ongoing

THOMSON REUTERS
·
Aug 05

Amgen Outlook FY Adjusted EPS USD 22.3-23.5

THOMSON REUTERS
·
Aug 05

Preview: Amgen Climbs Ahead of Earnings

Reuters
·
Aug 05

Vertex Pharmaceuticals Seen Well Positioned Ahead of Pipeline Catalysts, UBS Says

MT Newswires Live
·
Aug 05